VSTM
NASDAQ
$5.75
Verastem Inc (VSTM)
Verastem, Inc., a developing-stage biopharmaceutical company focused on developing and commercializing life-enhancing drugs for cancer patients. The company is headquartered in Needham, Massachusetts.
Sector:
Healthcare
Industry:
Biotechnology
Buy
Target: $15 (+160.87%)
Market Cap
$503M
FCF 5Y CAGR
+51.28%
Free Cash Flow Yield
-29.99%
Beta (5Y)
1.38
Price Chart
Valuation
Market Cap$503M
P/S9.87
P/B5.77
Profitability
Total Revenue (TTM)$50M
Gross Profit (TTM)$42M
EBITDA-$162M
Operating Margin-240.5%
EPS-$2.74
Financial Health
Free Cash Flow Yield-29.99%
Growth & Risk
EPS 5Y CAGR-2.77%
Revenue 5Y CAGR-10.11%
FCF 5Y CAGR+51.28%
Beta (5Y)1.38
Sharpe Ratio0.49